Critical Evaluation of Antibacterial Properties of MXenes

Authors:
Preprint
Publisher website
Google Scholar
Abstract
MXenes are well-known as highly biocompatible two-dimensional nanomaterials with a wide range of biomedical applications, including antibacterial strategies. However, the coexistence of high biocompatibility and reported strong antibacterial effects presents a fundamental contradiction that requires critical evaluation. In this study, we systematically investigated the antibacterial properties of pure Ti3C2Tx, Nb2CTx, V2CTx, and Ti3CNTx MXenes of varying flake sizes using multiple in vitro assays and an in vivo wound model. High-resolution structural and chemical characterizations confirmed the use of high-quality, minimally oxidized MXene samples with well-defined surface terminations. Despite using multiple evaluation methods, including disk diffusion, broth microdilution, time-kill kinetics, ROS quantification, and electron microscopy, no significant antibacterial effects were observed at sub-toxic concentrations. Furthermore, neither reactive oxygen species-mediated damage nor the hypothesized “nano-knife” mechanical disruption mechanism could be confirmed. This suggests that the previous observations of antibacterial properties resulted from incomplete removal of etching products or partial oxidation of MXenes. In contrast, we demonstrate that MXene-assisted photothermal therapy (PTT) under near-infrared laser irradiation offers highly effective and selective bacterial ablation. Ti3C2Tx MXene exhibited strong photothermal performance, achieving complete bacterial killing in vitro and significant wound healing efficacy in an in vivo murine model. Targeted PTT using antibody-functionalized MXenes enabled the eradication of E. coli while sparing non-target bacteria. These findings suggest that while intrinsic antibacterial properties of pristine MXenes are limited, their biocompatibility and photothermal responsiveness make them promising platforms for next-generation, externally triggered antibacterial therapies.
Funding Information
  • Narodowe Centrum Nauki (UMO-2020/38/E/ST5/00176)

This publication has 61 references indexed in Scilit: